Professionals and executives from the biopharma, health organizations, CROs, Digital Solutions, Policy Developers, and Medical Device Companies, are invited to attend the Health Equity In Clinical Trials Congress being held in Boston, February 22-23, 2023. Participants will get access to a wide spectrum of healthcare opportunities and the chance to meet and connect with veterans of the industry.
In the two main event days, 25+ leading industry speakers will gather on this forum to share their valuable insights in 5 keynote sessions, and will discuss tactful approaches to drive meaningful change for underrepresented communities through meaningful cross-industry networks and scaling equity initiatives. Attendees will get deeper insights from these equity change-makers to more fully understand strategies for expanding diversity, equity and inclusion programs, through industry action and technology.
The opening panel discussion topic will be on biopharma advancements for inclusive investigations and health equity programs, conducted by leading clinical trial experts in the industry.
Why attend the Clinical Trials Congress?
- Meet peers, advocates and industry experts and grow your business network
- Learn and understand from case studies, success stories, and experiences shared by your peers and leaders
- Make a list of all pointers that form a foundation for your business; strategies, roadmaps, and other insights offered by the stalwarts at the congress
- Attending the congress is a business investment that will also contribute to the personal growth of professionals and executives by increasing their knowledge base
Those interested in pitching their business or services at the conference can get curated packages that range from presenting their expertise on the main stage to hosting a private dinner. Interested candidates can partner with the event organizers at Kisaco Research to showcase their brand and make valuable new connections. There are 3 main categories: Thought Leadership, Branding & Networking.
If you would like to register a team of 3 or more, please email [email protected] for a discount coupon code before registering.
To learn more, please visit https://nnw.fm/pjTO0
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork
